Sunzen Biotech Berhad Balance Sheet Health
Financial Health criteria checks 6/6
Sunzen Biotech Berhad has a total shareholder equity of MYR149.8M and total debt of MYR6.5M, which brings its debt-to-equity ratio to 4.3%. Its total assets and total liabilities are MYR170.3M and MYR20.5M respectively. Sunzen Biotech Berhad's EBIT is MYR11.1M making its interest coverage ratio 45.3. It has cash and short-term investments of MYR27.6M.
Key information
4.3%
Debt to equity ratio
RM 6.49m
Debt
| Interest coverage ratio | 45.3x |
| Cash | RM 27.60m |
| Equity | RM 149.84m |
| Total liabilities | RM 20.49m |
| Total assets | RM 170.32m |
Recent financial health updates
Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?
Mar 26
Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?
Dec 10
Recent updates
Sunzen Biotech Berhad's (KLSE:SUNZEN) CEO Looks Due For A Compensation Raise
Dec 12Sunzen Biotech Berhad's (KLSE:SUNZEN) Promising Earnings May Rest On Soft Foundations
Nov 07Sunzen Biotech Berhad's (KLSE:SUNZEN) Shareholders Might Be Looking For Exit
Oct 15Sunzen Biotech Berhad's (KLSE:SUNZEN) Returns On Capital Are Heading Higher
Aug 06If EPS Growth Is Important To You, Sunzen Biotech Berhad (KLSE:SUNZEN) Presents An Opportunity
May 25Optimistic Investors Push Sunzen Biotech Berhad (KLSE:SUNZEN) Shares Up 27% But Growth Is Lacking
May 24Sunzen Biotech Berhad (KLSE:SUNZEN) Is Doing The Right Things To Multiply Its Share Price
Apr 22Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You
Nov 16Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?
Mar 26Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?
Dec 10Financial Position Analysis
Short Term Liabilities: SUNZEN's short term assets (MYR57.1M) exceed its short term liabilities (MYR8.0M).
Long Term Liabilities: SUNZEN's short term assets (MYR57.1M) exceed its long term liabilities (MYR12.5M).
Debt to Equity History and Analysis
Debt Level: SUNZEN has more cash than its total debt.
Reducing Debt: SUNZEN's debt to equity ratio has reduced from 15.1% to 4.3% over the past 5 years.
Debt Coverage: SUNZEN's debt is well covered by operating cash flow (151.4%).
Interest Coverage: SUNZEN's interest payments on its debt are well covered by EBIT (45.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 17:40 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sunzen Biotech Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|